| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.
Other companies in BioCryst Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
BioCryst Pharma has a consensus price target of $20.71.
The stock price for BioCryst Pharma (NASDAQ: BCRX) is $7.75 last updated October 16, 2026 at 7:03 PM EDT.
There are no upcoming dividends for BioCryst Pharma.
BioCryst Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for BioCryst Pharma.
BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
